Personal information

No personal information available

Biography

As a paediatric oncologist, I am a clinical leader at the Royal Children’s Hospital (RCH) with specialist expertise in leukaemia, haematopoietic stem cell transplantation, and cellular and novel therapies. I have a strong facilitory role in encouraging and leading research in the clinical environment as the deputy director of the Clinical Trials Unit (CTU) within the Children’s Cancer Centre (CCC), Principal Investigator (PI) of international collaborative clinical trials for acute leukaemia as well as RCH representative member of the Victorian Comprehensive Cancer Centre (VCCC) ‘Accelerating novel therapies’ steering group and the national Zero Childhood Cancer (ZCC) and PRecISion Medicine for children with cancer (PRISM) ALL and AML working groups. I am a passionate clinician-scientist having completed a translational laboratory based PhD (2021) and, as a post-doctoral researcher, continue to integrate cutting-edge cancer research into clinical care to improve the outcomes for our patients by building on what is known about the biology of treatment failure and leading appropriate clinical trials.

Activities

Collapse all

Employment (4)

University of Melbourne: VIC, VIC, AU

2022 to present | Honorary Senior Lecturer (Department of Paediatrics)
Employment
Source: Self-asserted source
Diane Hanna

Walter and Eliza Hall Institute of Medical Research: Melbourne, VIC, AU

2021 to present | Honorary postdoctoral research associate (Blood Cells and Blood Cancer Division)
Employment
Source: Self-asserted source
Diane Hanna

Murdoch Children's Research Institute: Melbourne, Victoria, AU

2021 to present | Honorary postdoctoral fellow
Employment
Source: Self-asserted source
Diane Hanna

Royal Children's Hospital: Melbourne, Victoria, AU

2015 to present | Paediatric Oncologist (Children's Cancer Centre)
Employment
Source: Self-asserted source
Diane Hanna

Education and qualifications (3)

Royal Australasian College of Physicians: Sydney, New South Wales, AU

2015 to present | FRACP
Qualification
Source: Self-asserted source
Diane Hanna

The University of Melbourne: Melbourne, VIC, AU

2021 | PhD
Education
Source: Self-asserted source
Diane Hanna

Monash University: Melbourne, Victoria, AU

2007 | MBBS hon
Education
Source: Self-asserted source
Diane Hanna

Professional activities (18)

Royal Children's Hospital: Melbourne, Victoria, AU

2022 to present | CCC Lead for RCH Research Innovation and Implementation Committee
Service
Source: Self-asserted source
Diane Hanna

Royal Children's Hospital: Melbourne, Victoria, AU

2022 to present | Deputy Director of CCC Clinical Trials Unit
Service
Source: Self-asserted source
Diane Hanna

Victorian Comprehensive Cancer Centre: Melbourne, Victoria, AU

2021 to present | Steering Group Member for ‘Program 3: Accelerate Novel Therapies’
Service
Source: Self-asserted source
Diane Hanna

Victorian Comprehensive Cancer Centre: Melbourne, Victoria, AU

2021 to present | ‘Drug Formulary’ working group member
Service
Source: Self-asserted source
Diane Hanna

Victorian Comprehensive Cancer Centre: Melbourne, Victoria, AU

2021 to present | 'Clinical Trialist Development Hub’ working group member
Service
Source: Self-asserted source
Diane Hanna

Victorian Comprehensive Cancer Centre: Melbourne, Victoria, AU

2021 to present | Increase Awareness and Access to Early Phase Cancer Clinical Trials’ working group member
Service
Source: Self-asserted source
Diane Hanna

Royal Children's Hospital: Melbourne, Victoria, AU

2021 to present | Member of the Drug Trial Sub-Committee
Service
Source: Self-asserted source
Diane Hanna

Children's Cancer Institute Australia: Randwick, New South Wales, AU

2021 to present | ALL and AML - Expert working group member (Expert member of the national Zero Childhood Cancer (ZCC) and PRecISion Medicine for children with cancer (PRISM) 2.0 )
Service
Source: Self-asserted source
Diane Hanna

Royal Children's Hospital: Melbourne, Victoria, AU

2020 to present | Medical Delegate for the Victorian Cord Blood Bank
Service
Source: Self-asserted source
Diane Hanna

Paediatric Integrated Cancer Service: Parkville, Victoria, AU

2018 to present | Chair of the Statewide Paediatric Integrated Cancer Service (PICS) Leukaemia/HSCT multi-disciplinary team meeting (MDM)
Service
Source: Self-asserted source
Diane Hanna

Paediatric Integrated Cancer Service: Parkville, Victoria, AU

2018 to present | Member of the Clinical Management Advisory Committee
Service
Source: Self-asserted source
Diane Hanna

Paediatric Integrated Cancer Service: Parkville, Victoria, AU

2018 to present | Member if the Infectious Disease Oncology Leadership Group
Service
Source: Self-asserted source
Diane Hanna

American Society of Hematology: DC, DC, US

2018 to present
Membership
Source: Self-asserted source
Diane Hanna

Children's Oncology Group: Monrovia, California, US

2016 to present
Membership
Source: Self-asserted source
Diane Hanna

European School of Haematology: Paris, FR

2014 to present
Membership
Source: Self-asserted source
Diane Hanna

ANZCHOG: Clayton, Victoria, AU

2012 to present
Membership
Source: Self-asserted source
Diane Hanna

Leukaemia Foundation: ACT, ACT, AU

2021 | Working group member of the Australian National Optimal Care Pathway (OCP) for Children And Young Adults (CAYA) with acute leukaemia
Service
Source: Self-asserted source
Diane Hanna

Victorian Comprehensive Cancer Centre: Melbourne, Victoria, AU

2016 | Scientific Committee Member for the Inaugural VCCC Research Conference
Service
Source: Self-asserted source
Diane Hanna

Funding (4)

Retrospective cohort study to define epigenetic subclasses through methylation profiling of paediatric AML

2022 to present | Grant
David Collins Leukaemia foundation (Hobart, AU)
Source: Self-asserted source
Diane Hanna

Identifying and overcoming resistance in high-risk acute lymphoblastic leukaemia

2019 to 2020 | Grant
Kids' Cancer Project (NSW, NSW, AU)
Source: Self-asserted source
Diane Hanna

Identifying and overcoming resistance in high-risk acute lymphoblastic leukaemia

2016 to 2018 | Salary award
Cancer Therapeutics Cooperative Research Centre (VIC, VIC, AU)
Source: Self-asserted source
Diane Hanna

Identifying and overcoming resistance in high-risk acute lymphoblastic leukaemia

2015 to 2017 | Salary award
University of Melbourne (Melbourne, Victoria, AU)
Source: Self-asserted source
Diane Hanna

Works (16)

Identifying Risk Factors for Central Venous Access Device Complications in Pediatric Patients With Cancer: A Scoping Review

European Journal of Cancer Care
2025-01 | Journal article
DOI: 10.1155/ecc/9956694
Contributors: Jenna L. Nunn; Mari D. Takashima; Erin M. Wray-Jones; Trisha A. Soosay Raj; Diane M. Hanna; Amanda J. Ullman; Lalit Batra
Source: check_circle
Crossref

Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?

Expert Review of Anti-infective Therapy
2023-03-04 | Journal article
DOI: 10.1080/14787210.2023.2171987
Contributors: Coen Butters; Karin Thursky; Diane T Hanna; Theresa Cole; Andrew Davidson; Jim Buttery; Gabrielle Haeusler
Source: check_circle
Crossref

Cardio-oncology guidelines for pediatric oncology patients: A Delphi Consensus

Lancet Oncology
2022 | Journal article
Source: Self-asserted source
Diane Hanna

Novel approaches to the management of pulmonary infiltrates in the pediatric HSCT patient

Current Opinions in Infectious Diseases
2022 | Journal article
Source: Self-asserted source
Diane Hanna

Early versus late stopping of antibiotics in febrile neutropenia (ELSA FN): An embedded randomised clinical trial

ANZCHOG
2021 | Conference abstract
Source: Self-asserted source
Diane Hanna

Identifying and overcoming therapeutic resistance in high-risk ALL

2021 | Dissertation or Thesis
Source: Self-asserted source
Diane Hanna

Promoting positive physical activity behaviours for children and adolsecnts undergoing acute cancer treatment: development of the CanMOVE intervention using the Behaviour Change Wheel

ANZCHOG
2021 | Conference abstract
Source: Self-asserted source
Diane Hanna

. A nurse-led paediatric oncology fast-track clinic proves a successful ambulatory intervention for patients

Support Care Cancer
2020 | Journal article
Source: Self-asserted source
Diane Hanna

Cotargeting BCL-2 and MCL-1 in high-risk B-ALL

Blood advances
2020 | Journal article
Source: Self-asserted source
Diane Hanna

Haematology & Oncology Chapter

Royal Children’s Hospital Paediatric Handbook 10th Edition
2020 | Book chapter
Source: Self-asserted source
Diane Hanna

Haploidentical HSCT in Children with Very High-Risk Hematologic Malignancies: A single centre experience

BMT
2020 | Journal article
Source: Self-asserted source
Diane Hanna

Immunological investigations undertaken for children diagnosed with lymphoma at a single centre in Australia from 2016-2019

ESID
2019 | Conference poster
Source: Self-asserted source
Diane Hanna

. Identification of potent BH3-mimetic combinations targeting pro-survival pathways in human B-cell acute lymphoblastic leukemia

ASH
2018 | Conference abstract
Source: Self-asserted source
Diane Hanna

Dysregulation of BCL-2 Family Proteins by Leukaemia Fusion Genes

Journal of Biological Chemistry
2017 | Journal article
Source: Self-asserted source
Diane Hanna

A New Approach to High Risk Pediatric Acute Lymphoblastic Leukemia?

Translational Cancer Research
2016 | Journal article
Source: Self-asserted source
Diane Hanna

Haematology & Oncology

Royal Children's Hospital Paediatric Handbook 9th Edition
2015 | Book chapter
Source: Self-asserted source
Diane Hanna
How many people are using ORCID?